The Company announces that the results of the general meeting held today at BioCity, Nottingham were as follows:
The total votes cast represented 39.6% of the Company’s total voting rights.
None of the resolutions were therefore carried.
On 18 December, the Company announced the issue of warrants over 420 million new ordinary shares (the “Warrants”), conditional upon shareholder approval at a general meeting. With resolutions 1 and 2 not having been passed, the Warrants will not be issued.
Resolutions 3 and 4 related to the Company’s ability to issue shares. With these resolutions also not having been passed, the Company’s existing authorities, which were passed at last year’s annual general meeting, remain in existence. Under these authorities, the Company has the power to issue up to 172 million shares. There are no plans at the current time to use these authorities to raise further capital. However, the Company is reviewing the remuneration packages of employees across its subsidiaries, which will include the issue of a small number of options to those staff.
Antony Legge, Chairman of RMS, said: “The Board has taken note of the depth of feeling amongst the Company’s shareholders and hopes that with the defeat of these resolutions a line can be drawn under the past. The Board is committed to improving shareholder communication, not least with the recent appointment of a specialist investor relations advisor and a new dedicated email address ([email protected]) for shareholders to ask questions.”
